Heron Therapeutics (HRTX) EPS (Basic) (2010 - 2026)
Heron Therapeutics (HRTX) reported EPS (Basic) of -$0.04 for Q1 2026, down 300.0% on a YoY basis from $0.02 in Q1 2025, and down 300.0% quarter-over-quarter from -$0.01 in Q4 2025.
Heron Therapeutics (HRTX) EPS (Basic) (2010 - 2026) Analysis & Trends
Heron Therapeutics has reported EPS (Basic) for 17 years, with the latest figure at -$0.04 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 300.0% year-over-year to -$0.04; the trailing twelve-month figure through Mar 2026 stood at -$0.17 (down 240.0% YoY), and the FY2025 full-year result was -$0.12, down 33.33% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.04, down from -$0.01 in the prior quarter.
- The five-year high for EPS (Basic) was $0.02 in Q4 2024, with the low at -$0.63 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.16 across 5 years, with a median of -$0.06 in 2024.
- Annual changes were most pronounced in 2025 — EPS (Basic) surged 200.0% — and 2026, when it sank 300.0%.
- Heron Therapeutics' EPS (Basic) stood at -$0.13 in 2022, then soared by 61.54% to -$0.05 in 2023, then soared by 140.0% to $0.02 in 2024, then slumped by 150.0% to -$0.01 in 2025, then sank by 300.0% to -$0.04 in 2026.
- The last three EPS (Basic) figures came in at -$0.04 (Q1 2026), -$0.01 (Q4 2025), and -$0.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.06 |
| 10 | Heron Therapeutics | 85.57 Mn | 55.60 Mn | 24.07 Mn | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.01 |
| Sep 30, 2025 | -0.10 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | -0.03 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.02 |
| Dec 31, 2023 | -0.05 |
| Sep 30, 2023 | -0.17 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.27 |
| Dec 31, 2022 | -0.13 |
| Sep 30, 2022 | -0.38 |
| Jun 30, 2022 | -0.55 |
| Mar 31, 2022 | -0.63 |
| Dec 31, 2021 | -0.53 |
| Sep 30, 2021 | -0.51 |
| Jun 30, 2021 | -0.62 |